Hortobagyi GN - Search Results

1

Blocking c-Met and EGFR reverses acquired resistance of PARP inhibitors in triple-negative breast cancer.

Chu YY, Yam C, Chen MK, Chan LC, Xiao M, Wei YK, Yamaguchi H, Lee PC, Han Y, Nie L, Sun X, Moulder SL, Hess KR, Wang B, Hsu JL, Hortobagyi GN, Litton J, Chang JT, Hung MC. Chu YY, et al. Among authors: hortobagyi gn. Am J Cancer Res. 2020 Feb 1;10(2):648-661. eCollection 2020. Am J Cancer Res. 2020. PMID: 32195033 Free PMC article.

2

Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?

Buzdar AU, McNeese MD, Hortobagyi GN, Smith TL, Kau S, Fraschini G, Hug V, Ellerbroek N, Holmes FA, Ames F, et al. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1990 Feb 1;65(3):394-9. doi: 10.1002/1097-0142(19900201)65:3<394::aid-cncr2820650303>3.0.co;2-2. Cancer. 1990. PMID: 2297630

3

Sequential cyclic combined hormonal therapy for metastatic breast cancer.

Hortobagyi GN, Hug V, Buzdar AU, Kau SW, Holmes FA, Fritsche HA. Hortobagyi GN, et al. Cancer. 1989 Sep 1;64(5):1002-6. doi: 10.1002/1097-0142(19890901)64:5<1002::aid-cncr2820640505>3.0.co;2-b. Cancer. 1989. PMID: 2527085

4

Role of adjuvant chemotherapy in male breast cancer.

Patel HZ 2nd, Buzdar AU, Hortobagyi GN. Patel HZ 2nd, et al. Among authors: hortobagyi gn. Cancer. 1989 Oct 15;64(8):1583-5. doi: 10.1002/1097-0142(19891015)64:8<1583::aid-cncr2820640804>3.0.co;2-q. Cancer. 1989. PMID: 2676137 Clinical Trial.

5

Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.

Hortobagyi GN, Ames FC, Buzdar AU, Kau SW, McNeese MD, Paulus D, Hug V, Holmes FA, Romsdahl MM, Fraschini G, et al. Hortobagyi GN, et al. Cancer. 1988 Dec 15;62(12):2507-16. doi: 10.1002/1097-0142(19881215)62:12<2507::aid-cncr2820621210>3.0.co;2-d. Cancer. 1988. PMID: 3056604 Review.

6

Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.

Buzdar AU, Hortobagyi GN, Smith TL, Kau S, Marcus C, Holmes FA, Hug V, Fraschini G, Ames FC, Martin RG. Buzdar AU, et al. Among authors: hortobagyi gn. Cancer. 1988 Nov 15;62(10):2098-104. doi: 10.1002/1097-0142(19881115)62:10<2098::aid-cncr2820621005>3.0.co;2-b. Cancer. 1988. PMID: 3179922 Clinical Trial.

7

Combined antiestrogen and cytotoxic therapy with pseudomonas vaccine immunotherapy for metastatic breast cancer. A prospective, randomized trial.

Hortobagyi GN, Buzdar AU, Frye D, Hug V, Fraschini G, Ames FC, Montague E, Gutterman JU, Martin RG. Hortobagyi GN, et al. Cancer. 1987 Dec 1;60(11):2596-604. doi: 10.1002/1097-0142(19871201)60:11<2596::aid-cncr2820601103>3.0.co;2-n. Cancer. 1987. PMID: 3315173 Clinical Trial.

8

Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma.

Ro J, North SM, Gallick GE, Hortobagyi GN, Gutterman JU, Blick M. Ro J, et al. Among authors: hortobagyi gn. Cancer Res. 1988 Jan 1;48(1):161-4. Cancer Res. 1988. PMID: 3334990

9

The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer.

Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L, Hung MC. Chang JY, et al. Among authors: hortobagyi gn. Oncogene. 1997 Feb 6;14(5):561-8. doi: 10.1038/sj.onc.1200861. Oncogene. 1997. PMID: 9053854

10

Overexpression of both p185c-erbB2 and p170mdr-1 renders breast cancer cells highly resistant to taxol.

Yu D, Liu B, Jing T, Sun D, Price JE, Singletary SE, Ibrahim N, Hortobagyi GN, Hung MC. Yu D, et al. Among authors: hortobagyi gn. Oncogene. 1998 Apr 23;16(16):2087-94. doi: 10.1038/sj.onc.1201729. Oncogene. 1998. PMID: 9572489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,108 results

Search Page

Filters